New method for cell investigation
A unique technique enables researchers in Tübingen to follow what happens in brain cells in neurodegenerative diseases ̶ as if they were watching a live…
i3D-Markers
With the help of "i3D markers" - Dr. Hayder Amin and Dr. Caghan Kizil from the DZNE site in Dresden want to accelerate the development of drugs against brain diseases. To this end, they…
EU-Atlas: Dementia & Migration
General introduction
For people with a migration background who are affected by dementia, access to medical information, medical care and care services can prove…
A drug from immunotherapy could slow down the progression of the severe neurodegenerative disease.
A drug from immunotherapy could slow down the progression of the severe neurodegenerative…
Congratulations! Monique M.B. Breteler ranked among the top female scientists in the world
Research.com, a leading academic platform for researchers, have released the 2022 edition of their…
Prof. René Thyrian is new board member of Alzheimer Europe
On October 17th 2022, Prof. René Thyrian, group leader at the DZNE Rostock/Greifswald, was elected as new member to the 2022-2024 Board…
Background and literature
Patent filed: WO2020221937A1 Anti-GA efficacy in cellular models: https://www.embopress.org/doi/full/10.15252/emmm.201607054 (open access) …
GA-VAX
THE CHALLENGE
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease and the available medications extend life by only a few months.
With a lifetime risk of about…
Curriculum Vitae
Degrees 2014 Habilitation, Ludwig-Maximilians-Universität München, Germany 2007 Dr. med. (summa cum laude), Ludwig-Maximilians-Universität…
The speech of patients with neurodegenerative diseases gradually changes. Thanks to the help of artificial intelligence, even the slightest changes can become the basis for a diagnosis.
The speech of…
